Neurotrophins in healthy and diseased skin

Dermato-Endocrinology

Volumn 3, Issue 1, 2011, Pages 32-36

  Truzzi, Francesca ^a   Marconi, Alessandra ^a   Pincelli, Carlo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Fibroblasts; Keratinocytes; Melanocytes; Melanoma; Neurotrophins; p75NTR; Psoriasis; Trk

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN;

CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; HUMAN; MELANOCYTE; MELANOMA; MOLECULAR BIOLOGY; NERVE CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASE;

EID: 79951794518     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.3.1.14661     Document Type: Review

References (67)

1. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 2003; 72:609-42. (Pubitemid 36930455)
2. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237:1154-62. (Pubitemid 17124912)
3. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1:549-53.
4. Segal RA. Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 2003; 26:299-330. (Pubitemid 37064936)
5. Thoenen H, Barde YA. Physiology of nerve growth factor. Physiol Rev 1980; 60:1284-335.
6. Indo Y. Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum Mutat 2001; 18:462-71. (Pubitemid 33131549)
7. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 2004; 7:1187-9. (Pubitemid 39426236)
8. Ultsch MH, Wiesmann C, Simmons LC, Henrich J, Yang M, Reilly D, et al. Crystal structures of the neurotrophin- binding domain of TrkA, TrkB and TrkC. J Mol Biol 1999; 290:149-59. (Pubitemid 29308581)
9. Clary DO, Reichardt LF. An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3. Proc Natl Acad Sci USA 1994; 91:11133-7. (Pubitemid 24349640)
10. Strohmaier C, Carter BD, Urfer R, Barde YA, Dechant G. A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor. EMBO J 1996; 15:3332-7. (Pubitemid 26231939)
11. Luberg K, Wong J, Weickert CS, Timmusk T. Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J Neurochem 2010; 113:952-64.
12. Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, Ichim G, Delcros JG, Raquin MA, et al. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest 2010; 120:850-8.
13. Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, Zhang L, et al. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 2010; 467:59-63.
14. Rodriguez-Tébar A, Dechant G, Barde YA. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 1990; 4:487-92. (Pubitemid 20160838)
15. Frade JM, Barde YA. Nerve growth factor: two receptors, multiple functions. Bioessays 1998; 20:137-45. (Pubitemid 28132109)
16. He XL, Garcia KC. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004; 304:870-5. (Pubitemid 38620186)
17. Murray SS, Perez P, Lee R, Hempstead BL, Chao MV. A novel p75 neurotrophin receptor-related protein, NRH2, regulates nerve growth factor binding to the TrkA receptor. J Neurosci 2004; 24:2742-9. (Pubitemid 38380951)
18. Dechant G, Barde YA. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5:1131-6. (Pubitemid 35247171)
19. Wang JJ, Tasinato A, Ethell DW, Testa MP, Bredesen DE. Phosphorylation of the common neurotrophin receptor p75 by p38beta2 kinase affects NFkappaB and AP-1 activities. J Mol Neurosci 2000; 15:19-29. (Pubitemid 32104602)
20. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427:843-8. (Pubitemid 38297746)
21. Kaplan DR, Miller FD. Neurobiology: a move to sort life from death. Nature 2004; 427:798-9. (Pubitemid 38297730)
22. Montaño JA, Pérez-Piñera P, García- Suárez O, Cobo J, Vega JA. Development and neuronal dependence of cutaneous sensory nerve formations: Lessons from neurotrophins. Microsc Res Tech 2010; 73:513-29.
23. Davis BM, Fundin BT, Albers KM, Goodness TP, Cronk KM, Rice FL. Overexpression of nerve growth factor in skin causes preferential increases among innervation to specific sensory targets. J Comp Neurol 1997; 387:489-506. (Pubitemid 27467434)
24. Pincelli C, Fantini F, Giannetti A. Nerve growth factor and the skin. Int J Dermatol 1994; 33:308-12. (Pubitemid 24202745)
25. Di Marco E, Marchisio PC, Bondanza S, Franzi AT, Cancedda R, De Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991; 266:21718-22. (Pubitemid 121000239)
26. Yaar M, Grossman K, Eller M, Gilchrest BA. Evidente for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 1991; 115:821-8. (Pubitemid 21909933)
27. Botchkarev VA, Metz M, Botchkareva NV, Welker P, Lommatzsch M, Renz H, et al. Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4 act as "epitheliotrophins" in murine skin. Lab Invest 1999; 79:557-72.
28. Marconi A, Terracina M, Fila C, Franchi J, Bonté F, Romagnoli G, et al. Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol 2003; 121:1515-21. (Pubitemid 38005507)
29. Marconi A, Vaschieri C, Zanoli S, Giannetti A, Pincelli C. Nerve growth factor protects human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol 1999; 113:920-7. (Pubitemid 30013332)
30. Stefanato CM, Yaar M, Bhawan J, Philips TJ, Kosmadaki MG, Botchkarev V, et al. Modulations of nerve growth factor and Bcl-2 in ultraviolet-irradiated human epidermis. J Cutan Pathos 2003; 30:351-7. (Pubitemid 36842949)
31. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, et al. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 1993; 268:22838-46. (Pubitemid 23318348)
32. Paus R, Lüftl M, Czarnetzki BM. Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol 1994; 130:174-80. (Pubitemid 24204611)
33. Pincelli C, Haake AR, Benassi L, Grassilli E, Magnoni C, Ottani D, et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): a role for BCL-2. J Invest Dermatol 1997; 109:757-64. (Pubitemid 28053525)
34. Tiberio R, Marconi A, Fila C, Fumelli C, Pignatti M, Krajewski S, et al. Keratinocytes enriched for stem cells are protected from anoikis via an integrin signaling pathway in a Bcl-2 dependent manner. FEBS Lett 2002; 524:139-44. (Pubitemid 34804849)
35. Pincelli C, Yaar M. Nerve growth factor: its significance in cutaneous biology. J Invetig Dermatol Symp Proc 1997; 2:61-8.
36. Yaar M. Neurotrophins in skin. In: Neurotrophins and the neural crest (Sieber-Blum M, Ed), Boston-London: CRC Press 1999; 117-40.
37. Marconi A, Panza MC, Bonnet-Duquennoy M, Lazou K, Kurfurst R, Truzzi F, et al. Espression and function of neurotrophins and their receptors in human melanocytes. Int J Cosmet Sci 2006; 28:255-61. (Pubitemid 44086779)
38. Peacocke M, Yaar M, Mansur CP, Chao MV, Gilchrest BA. Induction of nerve growth factor receptor on cultured human melanocytes. Proc Natl Acad Sci USA 1988; 85:5282-6.
39. Zhai S, Yaar M, Doyle SM, Gilchrest BA. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp Cell Res 1996; 224-335.
40. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990; 85:1085.
41. Yaar M, Eller MS, DiBenedetto P, Reenstra WR, Zhai S, McQuaid T, et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 1994; 94:1550-62.
42. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001; 98:6162-7. (Pubitemid 32488210)
43. Micera A, Lambiase A, Stampachiacchiere B, Sgrulletta R, Normando EM, Bonini S, et al. Nerve growth factor has a modulatory role on human primary fibroblast cultures derived from vernal keratoconjunctivitis-affected conjunctiva. Mol Vis 2007; 13:981-7. (Pubitemid 46971569)
44. Landi F, Aloe L, Russo A, Cesari M, Onder G, Bonini S, et al. Topical Treatment of Pressure Ulcers with Nerve Growth Factor. A Randomized Clinical Trial. Ann Int Med 2003; 139:635-41.
45. Aloe L, Tirassa P, Lambiase A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol Res 2008; 57:253-8.
46. Sun W, Lin H, Chen B, Zhao W, Zhao Y, Xiao Z, et al. Collagen scaffolds loaded with collagen-binding NGFbeta accelerate ulcer healing. J Biomed Mater Res A 2010; 92:887-95.
47. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 1999; 162:4271-6. (Pubitemid 29314818)
48. NTR expression is strongly induced in lesional atopic mast cells. Clin Exp Allergy 2008; 38:1168-73.
49. Kawamoto K, Aoki J, Tanaka A, Itakura A, Hosono H, Arai H, et al. Nerve growth factor activates mast cells through the collaborative interaction with lysophosphatidylserine expressed on the membrane surface of activated platelets. J Immunol 2002; 168:6412-9. (Pubitemid 34620066)
50. Szeder V, Grim M, Kucera J, Sieber-Blum M. Neurotrophin-3 signaling in mammalian Merkel cell development. Dev Dyn 2003; 228:623-9. (Pubitemid 37493981)
51. Perez-Pinera P, García-Suarez O, Germanà A, Díaz-Esnal B, de Carlos F, Silos-Santiago I, et al. Characterization of sensory deficits in TrkB knockout mice. Neurosci Lett 2008; 433:43-7.
52. Kinkelin I, Stucky CL, Koltzenburg M. Postnatal loss of Merkel cells, but not of slowly adapting mechanoreceptors in mice lacking the neurotrophin receptor p75. Eur J Neurosci 1999; 11:3963-9. (Pubitemid 29537576)
53. Iwamoto S, Burrows RC, Agoff SN, Piepkorn M, Bothwell M, Schmidt R. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly Expressed in spindled melanomas. Am J Dermatopathol 2001; 23:288-94. (Pubitemid 32729436)
54. Iwamoto S, Odland PB, Piepkorn M, Bothwell M. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol 1996; 35:725-31. (Pubitemid 26389472)
55. Huttenbach Y, Prieto VG, Reed JA. Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation. J Cutan Pathol 2002; 29:562-8. (Pubitemid 35193300)
56. Lazova R, Tantcheva-Poor I, Sigal AC. p75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma. J Am Acad Dermatol 2010; 63:852-8.
57. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 1996; 23:205-10. (Pubitemid 26181307)
58. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, et al. Human melano-mainitiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466:133-7.
59. Marchetti D, Denkins Y, Reiland J, Greiter-Wilke A, Galjour J, Murry B, et al. Brainmetastatic melanoma: a neurotrophic perspective. Pathol Oncol Res 2003; 9:147-58.
60. Walch ET, Albino AP, Marchetti D. Correlation of overexpression of the low- affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells. Int J Cancer 1999; 82:112-20. (Pubitemid 29266115)
61. Shonukan O, Bagayogo I, McCrea P, Chao M, Hempstead B. Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin. Oncogene 2003; 22:3616-23. (Pubitemid 36765321)
62. Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B. Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome. Am J Clin Pathol 2004; 122:412-20. (Pubitemid 39145547)
63. Truzzi F, Marconi A, Lotti R, Dallaglio K, French LE, Hempstead BL, et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol 2008; 128:2031-40. (Pubitemid 352001206)
64. Fantini F, Magnoni C, Bracci-Laudiero L, Pincelli C. Nerve growth factor is increased in psoriatic skin. J Invest Dermatol 1995; 105:854-5. (Pubitemid 26005611)
65. Raychaudhuri SP, Jiang WY, Farber EM. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 1998; 78:84-6. (Pubitemid 28153332)
66. Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol 2000; 10:85-90. (Pubitemid 30116418)
67. Raychaudhuri SP, Sanyal M, Weltman H, Kundu-Raychaudhuri S. K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol 2004; 122:812-9. (Pubitemid 38471352)